(NASDAQ:CNTA), ORX750: Demonstrated potential best-in-class profile for treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH) in initial cohorts of ongoing Phase 2a study; Data mark first robust demonstration of oral OX2R agonist addressing wakefulness needs of patients across all three indications; Expect to initiate registrational program in Q1 2026 […]

SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) — MVP Ventures, a venture capital firm built to be the most valuable partner per dollar on a founder's cap table, today announced the close of Fund II at $125 million, up from a $35 million Fund I. This brings the firm's total assets under management to over

(Other OTC:OTCM),(OTC US:OTCM),(HKSE:1723),(Other OTC:MXXNF), NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Moon Inc. (HKEX: 1723; OTCQX: MXXNF), a leading operator in Hong Kong's prepaid products market, has qualified to trade on the OTCQX(R) Best Market.

(NASDAQ:UPB), – Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically significant and clinically meaningful effects on primary and key secondary endpoints when administered once every 12 weeks – – On-track to report top-line results from VALIANT Phase 2 trial in severe asthma in the first quarter

(NASDAQ:PSEC), NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (the “Company” or “Prospect”) today announced it expects to file with the Securities and Exchange Commission its report on Form 10-Q containing results for the fiscal quarter ended September 30, 2025 and to issue its earnings press release on Thursday, November

(NASDAQ:ALMU), GOLETA, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum computing, today announced that it has received a 2025 LEAP Award from Design World in the category of Advanced Materials for the company's

(NASDAQ:XFOR), Company's strategic focus and highest priority is now the advancement of the 4WARD Phase 3 chronic neutropenia trialPreviously announced workforce reductions resulted in $13M annualized cost savingsSuccessful completion of two financial transactions totaling $240.3M; cash runway now extends to the end of 2028 BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR),

(NYSE:BCO), Total revenue growth of 6% with 19% AMS/DRS organic growth AMS/DRS increased to 27% of trailing-twelve-month revenue Record third-quarter operating profit margin and EBITDA margin RICHMOND, Va., Nov. 05, 2025 (GLOBE NEWSWIRE) — The Brink's Company (NYSE:BCO), a leading global provider of cash and valuables management, digital retail solutions (DRS), and ATM managed services

(TSX-V:ELBM),(NASDAQ:ELBM), TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company“), a leader in advancing North America's critical minerals processing, has resumed construction at its cobalt sulfate refinery following the arrangement of approximately US$82 million in project financing. This brownfield expansion positions Electra to complete North

(TSX:MBX),(OTC US:MBXBF),(Other OTC:MBXBF), MISSISSAUGA, Ontario, Nov. 05, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)), a life sciences innovator, manufacturer, and exporter, announces that it is addressing a cybersecurity incident relating to a ransomware attack that has had no impact on operations but involved the theft of data. Microbix is actively